KEY FEATURES
Full Name | Tumor Necrosis Factor Receptor Superfamily, Member 1A |
---|---|
Synonym | TNF-R;TNF-R-I;TNF-R55;TNFAR;TNFR1;TNFR1-d2;TNFR55;TNFR60;p55;p55-R;p60;CD120a;FPF;MS5;TBP1; |
Assay Type | Sandwich |
Reactivity | Human |
Range | 7.81-500pg/mL |
Sensitivity | 4.69pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human TNFRSF1A in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TNFRSF1A. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TNFRSF1A and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TNFRSF1A, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TNFRSF1A. You can calculate the concentration of Human TNFRSF1A in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human TNFRSF1A ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 25.58 | 44.54 | 229.32 | 27.8 | 43.31 | 212.57 |
Standard deviation | 1.39 | 1.85 | 11.31 | 1.52 | 2.48 | 11.2 |
CV(%) | 5.42 | 4.15 | 4.93 | 5.45 | 5.73 | 5.27 |
RECOVERY
The recovery of Human TNFRSF1A spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 92-103 | 98 |
EDTA plasma (n=8) | 96-109 | 102 |
Cell culture media (n=8) | 85-97 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human TNFRSF1A in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Diseases associated with BRE ELISA Kit
Neoplasms | publications with BRE and Neoplasms |
Nervous System Diseases | publications with BRE and Nervous System Diseases |
Brain Diseases | publications with BRE and Brain Diseases |
Skin Diseases | publications with BRE and Skin Diseases |
Breast Neoplasms | publications with BRE and Breast Neoplasms |
Carcinoma | publications with BRE and Carcinoma |
Cardiovascular Diseases | publications with BRE and Cardiovascular Diseases |
Neoplasm Metastasis | publications with BRE and Neoplasm Metastasis |
Neoplasms, Experimental | publications with BRE and Neoplasms, Experimental |
Lung Diseases | publications with BRE and Lung Diseases |
Organs/Tissues associated with BRE ELISA Kit
Bone | publications with BRE and Bone |
Blood | publications with BRE and Blood |
Brain | publications with BRE and Brain |
Nerve | publications with BRE and Nerve |
Muscle | publications with BRE and Muscle |
Eye | publications with BRE and Eye |
Liver | publications with BRE and Liver |
Lung | publications with BRE and Lung |
Heart | publications with BRE and Heart |
Kidney | publications with BRE and Kidney |